Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer, ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Bains described FY25 as a year of consolidation for the biosimilars business. And with the expansion of Biocon's vertically integrated model into new geographies, he also anticipates the drugmaker ...

Current President & CEO Peter Bains will step down on 31 December 2018. He will also resign as a director of the Company simultaneously. Tamura, currently executive chairman, will become chairman ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an Additional Director, designated him as Managing Director & ...

Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer (a key managerial personnel), effective from 1 April 2025, ...